Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma

Nivolumab shows promising efficacy against metastatic melanoma. However, immune-related adverse events are of great concern. We herein report a case of persistent colitis that developed during nivolumab monotherapy and nivolumab readministration. An 82-year-old Japanese woman with recurrent melanoma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Intern Med
Autori principali: Fujii, Yosuke, Nishikawa, Yoshitaka, Nomura, Motoo, Miyamoto, Shin'ich, Uneno, Yu, Horimatsu, Takahiro, Muto, Manabu
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Japanese Society of Internal Medicine 2017
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938514/
https://ncbi.nlm.nih.gov/pubmed/29269640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8910-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi